| Eculizumab in Atypical Hemolytic-Uremic Syndrome. T Tanimoto, Y Oshima, M Kami New Engl J Med 369 (14), 1377-1380, 2013 | 1617* | 2013 |
| EGFR–TKI-associated interstitial pneumonitis in nivolumab-treated patients with non–small cell lung cancer Y Oshima, T Tanimoto, K Yuji, A Tojo JAMA oncology 4 (8), 1112-1115, 2018 | 244 | 2018 |
| Characteristics of drug-associated rhabdomyolysis: analysis of 8,610 cases reported to the US Food and Drug Administration Y Oshima Internal Medicine 50 (8), 845-853, 2011 | 83 | 2011 |
| An approach to elucidate potential mechanism of renal toxicity of arsenic trioxide A Sasaki, Y Oshima, A Fujimura Experimental hematology 35 (2), 252-262, 2007 | 73 | 2007 |
| Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT/enhancer-binding protein α in granulocyte colony-stimulating factor … A Numata, K Shimoda, K Kamezaki, T Haro, H Kakumitsu, K Shide, K Kato, ... Journal of Biological Chemistry 280 (13), 12621-12629, 2005 | 69 | 2005 |
| Granulocyte colony-stimulating factor-associated aortitis in the Japanese Adverse Drug Event Report database Y Oshima, S Takahashi, K Tani, A Tojo Cytokine 119, 47-51, 2019 | 59 | 2019 |
| Profile of rhythmic gene expression in the livers of obese diabetic KK-Ay mice H Ando, Y Oshima, H Yanagihara, Y Hayashi, T Takamura, S Kaneko, ... Biochemical and biophysical research communications 346 (4), 1297-1302, 2006 | 56 | 2006 |
| Conversion of interleukin-13 into a high affinity agonist by a single amino acid substitution Y Oshima, BH Joshi, RK Puri Journal of Biological Chemistry 275 (19), 14375-14380, 2000 | 55 | 2000 |
| Drug-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients Y Oshima, T Tanimoto, K Yuji, A Tojo Multiple Sclerosis Journal 25 (8), 1141-1149, 2019 | 52 | 2019 |
| Characterization of a powerful high affinity antagonist that inhibits biological activities of human interleukin-13 Y Oshima, RK Puri Journal of Biological Chemistry 276 (18), 15185-15191, 2001 | 50 | 2001 |
| Association of hepatitis B with antirheumatic drugs: a case-control study Y Oshima, H Tsukamoto, A Tojo Modern Rheumatology 23 (4), 694-704, 2013 | 42 | 2013 |
| Association between aortic dissection and systemic exposure of vascular endothelial growth factor pathway inhibitors in the Japanese Adverse Drug Event Report database Y Oshima, T Tanimoto, K Yuji, A Tojo Circulation 135 (8), 815-817, 2017 | 40 | 2017 |
| Suppression of an IL-13 autocrine growth loop in a human Hodgkin/Reed-Sternberg tumor cell line by a novel IL-13 antagonist Y Oshima, RK Puri Cellular immunology 211 (1), 37-42, 2001 | 37 | 2001 |
| DNA microarray analysis of hematopoietic stem cell-like fractions from individuals with the M2 subtype of acute myeloid leukemia Y Oshima, M Ueda, Y Yamashita, YL Choi, J Ota, S Ueno, R Ohki, ... Leukemia 17 (10), 1990-1997, 2003 | 30 | 2003 |
| Association between Acute Myelogenous Leukemia and Thrombopoietin Receptor Agonists in Patients with Immune Thrombocytopenia Y Oshima, K Yuj, T Tanimoto, Y Hinomura, A Tojo Internal Medicine 52 (19), 2193-2201, 2013 | 26 | 2013 |
| Protective effect of α-lipoic acid against arsenic trioxide–induced acute cardiac toxicity in rats M Kumazaki, H Ando, A Sasaki, T Koshimizu, K Ushijima, K Hosohata, ... Journal of pharmacological sciences 115 (2), 244-248, 2011 | 22 | 2011 |
| Interstitial lung disease and gefitinib N Murashige, T Tanimoto, Y Oshima New England Journal of Medicine 363 (16), 1578-1580, 2010 | 20 | 2010 |
| Fatal GVHD demonstrating an involvement of respiratory muscle following donor leukocyte transfusion (DLT) Y Oshima, S Takahashi, H Nagayama, K Nishiwaki, Y Kobayashi, A Tojo, ... Bone marrow transplantation 19 (7), 737-740, 1997 | 20 | 1997 |
| Successful treatment of cytomegalovirus colitis with ganciclovir in a patient with adult T cell leukemia lymphoma: case report Y Oshima, K Nishida, S Kawazoye, T Noda, F Arima, M Miyahara, ... Journal of chemotherapy 11 (3), 215-219, 1999 | 17 | 1999 |
| Recombinant human granulocyte colony‐stimulating factor (G‐CSF) combined conditioning regimen for allogeneic bone marrow transplantation (BMT) in standard‐risk myeloid leukemia S Takahashi, Y Oshima, S Okamoto, K Nishiwaki, H Nagayama, T Inoue, ... American journal of hematology 57 (4), 303-308, 1998 | 17 | 1998 |
Koichiro YujiProject Associate Professor, the Institute of Medical Science, the University of TokyoVerified email at umin.ac.jp
